Galperin, Irina
Mirelman, Anat
Schmitz-Hübsch, Tanja
Hsieh, Katherine L.
Regev, Keren
Karni, Arnon
Brozgol, Marina
Cornejo Thumm, Pablo
Lynch, Sharon G.
Paul, Friedemann
Devos, Hannes
Sosnoff, Jacob
Hausdorff, Jeffrey M. http://orcid.org/0000-0001-7544-5846
Clinical trials referenced in this document:
Documents that mention this clinical trial
Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial
https://doi.org/10.1007/s00415-022-11469-1
Funding for this research was provided by:
National Multiple Sclerosis Society (RG-1507-05433)
Article History
Received: 2 August 2022
Revised: 31 October 2022
Accepted: 1 November 2022
First Online: 11 November 2022
Declarations
:
: JJS reports funding from the National Institute of Health (R21AG073892, R21AG064308-01), National Multiple Sclerosis Society (MB-1807-31633, RG-1701-26862), ownership in Sosnoff Technologies, LLC, speaking fees from BrainWeek, and consulting fees from Xavor, Inc. AM and JMH report have submitted a patent application on the use of virtual reality, the intellectual property rights for which are held by the Tel Aviv Medical Center. None of the other authors have potential conflicts of interest to be disclosed.
: The trial was conducted in accordance with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Guidance Good Clinical Practice, the 1964 Declaration of Helsinki and its later amendments, local applicable law and regulatory requirements, was approved by institutional review boards and ethical committees of each participating center, and was registered in ClinicalTrials.gov (NCT02427997). All patients provided written informed consent before any study procedure was performed.
Free to read: This content has been made available to all.